Doseology Sciences Inc.
Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distribut… Read more
Doseology Sciences Inc. (DOSEF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.063x
Based on the latest financial reports, Doseology Sciences Inc. (DOSEF) has a cash flow conversion efficiency ratio of -0.063x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-105.70K) by net assets ($1.69 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Doseology Sciences Inc. - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Doseology Sciences Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Doseology Sciences Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Doseology Sciences Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Finsbury Growth & Income Trust
LSE:FGT
|
0.013x |
|
Select Sands Corp
PINK:SLSDF
|
0.036x |
|
At-Tahur Ltd.
KAR:PREMA
|
N/A |
|
Manila Broadcasting Co
PSE:MBC
|
0.055x |
|
Huddled Group Plc
LSE:HUD
|
-0.307x |
|
4 Less Group Inc
PINK:FLES
|
0.003x |
|
Ferronoux Holdings Inc
PSE:FERRO
|
0.003x |
|
Media Sentiment Inc
PINK:MSEZ
|
-1.028x |
Annual Cash Flow Conversion Efficiency for Doseology Sciences Inc. (2020–2025)
The table below shows the annual cash flow conversion efficiency of Doseology Sciences Inc. from 2020 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $1.40 Million | $-342.24K | -0.245x | -6.20% |
| 2024-06-30 | $1.02 Million | $-235.12K | -0.231x | +37.71% |
| 2023-06-30 | $1.30 Million | $-481.05K | -0.370x | +35.15% |
| 2022-06-30 | $3.00 Million | $-1.71 Million | -0.571x | +37.90% |
| 2021-06-30 | $2.58 Million | $-2.37 Million | -0.919x | -662.44% |
| 2020-06-30 | $1.07 Million | $-129.10K | -0.121x | -- |